透明质酸钠
医学
角膜内皮
光学相干层析成像
眼科
白内障手术
盐酸利多卡因
眼前节
外科
青光眼手术
角膜
利多卡因
青光眼
作者
Eleftherios Chatzimichail,António Cunha-Vaz Martinho,Kristina Heß,Konstantin Gugleta,Zisis Gatzioufas
出处
期刊:Klinische Monatsblatter Fur Augenheilkunde
[Thieme Medical Publishers (Germany)]
日期:2024-04-01
卷期号:241 (04): 381-384
被引量:1
摘要
Sodium hyaluronate 1% was first introduced to ophthalmic surgery in 1979 from Drs. Stegmann and Miller during cataract surgery [1]. Ophthalmic viscoelastic devices (OVDs) are widely used in anterior segment surgery, among others, in order to maintain anterior chamber depth intraoperatively and to protect the corneal endothelium [2]. Since the first use of sodium hyaluronate 1%, other viscoelastic agents have been developed and introduced into the operating theater, such as combinations of natrium hyaluronate with chondroitin sulfate and natrium hyaluronate with lidocaine hydrochloride [3], [4]. Intraoperative anterior segment ocular coherence tomography (i-AS-OCT) was first introduced in 2005 and offers the ability to assess the structures of anterior segment in real-time during surgery [5]. Of great importance is the noninvasive nature of OCT as well as the easy use of the device, which is often integrated in the surgical microscope [6].
科研通智能强力驱动
Strongly Powered by AbleSci AI